Looking for a GC that specializes in cardiovascular genetics? Check out our new Find a GC Map, an interactive tool to locate GCs specializing in cardiogenomic testing nationwide. Access to genetic counselors is key to increasing utilization of cardiovascular genomics.

Kicked off the #HRS2024 weekend hosting a luncheon with The SADS Foundation for the amazing cardiovascular genetic counselors attending this weekend!. Be sure to check out our “Find a Cardio GC” map on our website to search for generic counselors across the country.

RT @SADSFoundation: We’re so glad to be neighbors with our dear friends at @CardioGenomicTA! #HRS2024

We are all set and ready for #HRS2024! Stop by booth 1458 to learn more about the value of genomic testing in cardiology.

The CGTA team will be present at Heart Rhythm 2024 in Boston this May. Join us at booth #1458 to learn more about CGTA’s projects, educational materials, and membership opportunities. Please reach out to us if you are planning to attend.

CGTA is happy to announce the launch of the Find a Cardiovascular Genetic Counselor Map. This map allows providers and patients to find cardiovascular genetic counselors in specific areas. Increased access is key. Click here to see and utilize the map:

Olivia Roy, MS, CGC is our newest scientific advisor. A genetic counselor at the Texas Center for Pediatric and Congenital Heart Disease, she is dedicated to advancing patient care through genomics.

CGTA is happy to announce the addition of several cardiovascular genetic counselors to our growing list of scientific advisors. First up is Kate Orland, MS, LCGC, the primary cardiac genetic counselor at the University of Wisconsin Cardiac Genetics Clinic.

A JAMA Cardiology Original Investigation, published on 1/31, showed individuals with familial hypercholesterolemia variants had 2 times higher risk for coronary heart disease. This speaks to the clinical utility of genetic testing for FH.

A JAMA Cardiology Original Investigation, published on 1/31, showed individuals with familial hypercholesterolemia variants had 2 times higher risk for coronary heart disease. This speaks to the clinical utility of genetic testing for FH.

Genetic cardiomyopathy affects millions worldwide, and genetic testing plays a vital role in early diagnosis and management. The Genetic Cardiomyopathy Awareness Consortium is working to increase access to genetic testing for patients and families.

We stand with the Genetic Cardiomyopathy Awareness Consortium in its mission to increase awareness and utilization of genetic testing. Testing is crucial for identifying at-risk individuals, enabling early intervention and improved outcomes.

We are actively recruiting new members to join us and advocate for greater understanding and utilization of genomic testing in cardiology. Visit our website to learn more and then reach out today.

Today is CGTA’s 2-year anniversary!. 2 years of raising awareness and utilization of genomic testing in cardiology. 2 years of educating providers, patients, and families. 2 years of striving to make a real impact. Thank you to our dedicated members, partners, and advisors!

Earlier diagnosis. Earlier treatment. That’s the value of genomic testing in cardiology. If there is personal or family history of cardiac disease, genomic testing in cardiology can help identify any abnormalities and prevent future cardiac emergencies.

A recent article in Current Cardiology Reports provides an on-point assessment of the state of genetic testing in cardiology, as well as the benefits that we can expect from greater utilization across the entire cardiology community.

Cardiovascular disease is the leading cause of death in the United States. This Heart Month, we encourage providers to understand the clinical utility of genomic testing for certain heritable cardiovascular conditions. Visit our website to learn more.

Have you checked out our database of cardiogenomic testing guidelines, co-hosted with Northwestern University?. You’ll find a trove of clinically actionable guidelines, professional society consensus statements, reviews, and relevant research articles.

Caitlin Finn, MS, CGC, Licensed Genetic Counselor at Beth Israel Deaconess Medical Center for Cardiovascular Genetics, provides an overview of cardiovascular genetic testing and its value for the patient and their family members.

Index case testing and presymptomatic testing are important aspects of cardiogenetic testing. Dr. Michael Ackerman, genetic cardiologist at the @MayoClinic, breaks down the two categories and why they are necessary. Check out the full video here:.